SCHEMBL2550281

SCHEMBL2550281

COc1ccc2[nH]c(=O)c3sccc3c2c1-c1ccc(C(C)C(C)CN)cc1

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NEK1 Q96PY6 20/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2550053 0.90 NEK1 (1.00) NEK1
SCHEMBL2550946 0.90 NEK1 (1.00) NEK1
SCHEMBL2548619 0.90 NEK1 (1.00) NEK1
Hydrochloric Acid SCHEMBL15092224 0.89 NEK1 (0.98) NEK1
Hydrochloric Acid SCHEMBL15092182 0.89 NEK1 (0.98) NEK1
SCHEMBL2550278 0.88 NEK1 (1.00) NEK1
Hydrochloric Acid SCHEMBL15092093 0.87 NEK1 (0.98) NEK1
SCHEMBL12282363 0.87 NEK1 (1.00) NEK1
SCHEMBL2552085 0.87 NEK1 (1.00) NEK1
SCHEMBL2550416 0.87 NEK1 (1.00) NEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2552206-A1 TRYCYCLIC COMPOUNDS AND PBK INHIBITORS CONTAINING THE SAME OncoTherapy Science, Inc. (JP) 2013-02-06 EP claimed
WO-2011123419-A1 TRYCYCLIC COMPOUNDS AND PBK INHIBITORS CONTAINING THE SAME ONCOTHERAPY SCIENCE, INC. (JP) 2011-10-06 WO claimed
EP-2552206-A1 TRYCYCLIC COMPOUNDS AND PBK INHIBITORS CONTAINING THE SAME OncoTherapy Science, Inc. (JP) 2013-02-06 EP disclosed
WO-2011123419-A1 TRYCYCLIC COMPOUNDS AND PBK INHIBITORS CONTAINING THE SAME ONCOTHERAPY SCIENCE, INC. (JP) 2011-10-06 WO disclosed